{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T22:52:13Z","timestamp":1789253533692,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":507,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jtct.2021.09.020","type":"journal-article","created":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T09:15:50Z","timestamp":1633166150000},"page":"45.e1-45.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Haploidentical transplantation is feasible and associated with reasonable outcomes despite major infective complications\u2013A single center experience from India"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9847-9501","authenticated-orcid":false,"given":"Biju","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2230-2424","authenticated-orcid":false,"given":"Uday","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4558-7330","authenticated-orcid":false,"given":"Sharon","family":"Lionel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3587-8601","authenticated-orcid":false,"given":"Anup J.","family":"Devasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouzia N.","family":"Aboobacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha M.","family":"Lakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Selvarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Korula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winsley","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4040-5649","authenticated-orcid":false,"given":"George M.","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Rupali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy Sarojini","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0736-1445","authenticated-orcid":false,"given":"Asha","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aby","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jtct.2021.09.020_bib0001","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/S2352-3026(14)70021-3","article-title":"HLA match likelihoods for Indian patients seeking unrelate donor transplantation grafts: a population based study","volume":"1","author":"Maiers","year":"2014","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.jtct.2021.09.020_bib0002","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.020_bib0003","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/j.seminoncol.2012.09.005","article-title":"Post-transplant cyclophosphamide for tolerance induction in HLA haplo-identical bone marrow transplantation","volume":"39","author":"Luznik","year":"2012","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jtct.2021.09.020_bib0004","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3324\/haematol.2016.144139","article-title":"Comparable composite end points after HLA matched and HLA haplo-identical transplantation with post transplant cyclophosphamide","volume":"102","author":"McCurdy","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2021.09.020_bib0005","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bbmt.2014.05.029","article-title":"Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts","volume":"20","author":"Raiola","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.020_bib0006","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-018-0586-4","article-title":"Posttransplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT","volume":"11","author":"Ruggeri","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jtct.2021.09.020_bib0007","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood-2015-04-639831","article-title":"Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia","volume":"126","author":"Ciurea","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.09.020_bib0008","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbmt.2015.09.002","volume":"22","author":"Bashey","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.020_bib0009","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbmt.2012.08.014","article-title":"Unmanipulated haploidentical bone marrow transplantation and post transplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning","volume":"19","author":"Raiola","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.020_bib0010","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.bbmt.2015.03.003","article-title":"Total body irradiation-based myeloablative haploidentical stem cell transplantation is a safe and effective alternative to unrelated donor transplantation in patients without matched sibling donors","volume":"21","author":"Solomon","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.020_bib0011","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/cncr.31228","article-title":"Bone marrow versus mobilized peripheral blood stem cells in haplo-identical transplants using post transplantation cyclophosphamide","volume":"124","author":"Ruggeri","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2021.09.020_bib0012","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.hemonc.2020.01.003","article-title":"Haplo-identical stem cell transplant with post-transplantation cyclophosphamide and mini dose methotrexate in children","volume":"13","author":"Medina","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jtct.2021.09.020_bib0013","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.bbmt.2016.02.002","article-title":"Feasibility and outcome of haploidentical hematopoietic stem cell transplantation with post-transplant high-dose cyclophosphamide for children and adolescents with hematologic malignancies: an AIEOP-GITMO retrospective multicenter study","volume":"22","author":"Berger","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.020_bib0014","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/bjh.13406","article-title":"Acute myeloid leukemia: challenges and real world data from India","volume":"170","author":"Philip","year":"2015","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jtct.2021.09.020_bib0015","doi-asserted-by":"crossref","first-page":"e13273","DOI":"10.1111\/tid.13273","article-title":"Drug-resistant organisms are common in fecal surveillance cultures, predict bacteremia and correlate with poorer outcomes in patients undergoing allogeneic stem cell transplants","volume":"22","author":"Korula","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jtct.2021.09.020_bib0016","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bmt.2011.110","article-title":"The EBMT risk score","volume":"47","author":"Gratwohl","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.020_bib0017","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1182\/bloodadvances.2016002386","article-title":"Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1","volume":"1","author":"Versius","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2021.09.020_bib0018","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s00277-018-3433-3","article-title":"Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients","volume":"97","author":"Brunello","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2021.09.020_bib0019","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/ejh.13536","article-title":"Haplo-identical transplantation in pediatric non-malignant diseases: a retrospective analysis on behalf of the Spanish Group for Hematopoietic Transplantation (GETH)","volume":"106","author":"Canizales","year":"2021","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2021.09.020_bib0020","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-021-01113-4","article-title":"Haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide for children with non-malignant diseases (e-pub ahead of print August 6, 2021)","author":"Hashem","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jtct.2021.09.020_bib0021","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.bbmt.2020.03.018","article-title":"HLA-haploidentical hematopoietic cell transplantation for treatment of non-malignant diseases using nonmyeloablative conditioning and post-transplant cyclophosphamide","volume":"26","author":"Mallhi","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.020_bib0022","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood-2015-04-639831","article-title":"Haplo-identical transplant with post-transplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia","volume":"126","author":"Ciurea","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.09.020_bib0023","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/0284186X.2020.1837947","article-title":"Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide","volume":"60","author":"Chevallier","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jtct.2021.09.020_bib0024","doi-asserted-by":"crossref","first-page":"12432","DOI":"10.1038\/s41409-021-01328-4","article-title":"Severe infections and infection related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide","volume":"56","author":"Esquirol","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.020_bib0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbmt.2017.08.024","article-title":"Pre-engraftment bloodstream infections after allogeneic hematopoietic cell transplantation: impact of T cell-replete transplantation from a haploidentical donor","volume":"24","author":"Milkulska","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.020_bib0026","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.bbmt.2020.01.013","article-title":"Infections after allogeneic transplant with post-transplant cyclophosphamide: impact of donor HLA matching","volume":"26","author":"Oltolini","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.020_bib0027","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1182\/blood.2020009362","article-title":"Post-transplant cyclophosphamide is associated with increased cytomegalovirus infection: A CIBMTR analysis","volume":"137","author":"Goldsmith","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2021.09.020_bib0028","doi-asserted-by":"crossref","first-page":"478.e1","DOI":"10.1016\/j.jtct.2021.03.010","article-title":"Feasibility and efficacy of CD45RA+ depleted donor lymphocytes infusion after haploidentical transplantation with post-transplantation cyclophosphamide in patients with hematological malignancies","volume":"27","author":"Castagna","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2021.09.020_bib0029","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bbmt.2018.12.142","article-title":"Higher Incidence of Hemorrhagic Cystitis Following Haploidentical Related Donor Transplantation Compared with Matched Related Donor Transplantation","volume":"25","author":"Copelan","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.020_bib0030","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00277-020-03930-w","article-title":"Impact of extended infusional mesna prophylaxis on the incidence of BK viruria and hemorrhagic cystitis following post-transplantation cyclophosphamide and CTLA4Ig-based haploidentical transplantation","volume":"99","author":"Jaiswal","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2021.09.020_bib0031","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/tid.12365","article-title":"Infections after T-replete haplo-identical transplantation and high-dose cyclophosphamide as graft versus host disease prophylaxis","volume":"17","author":"Crocchiolo","year":"2015","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.jtct.2021.09.020_bib0032","doi-asserted-by":"crossref","first-page":"e12629","DOI":"10.1111\/tid.12629","article-title":"Epidemiology of infections following haplo-identical peripheral blood stem cell transplantation","volume":"19","author":"Slade","year":"2017","journal-title":"Transplant Infect Dis"},{"issue":"10","key":"10.1016\/j.jtct.2021.09.020_bib0033","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.bbmt.2020.06.026","article-title":"Timing of post-transplant cyclophosphamide administration in haplo-identical transplantation: a comparative study on behalf of the acute leukemia working party of the European Society for Blood and Marrow transplantation","volume":"26","author":"Ruggeri","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.09.020_bib0034","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000507536","article-title":"Post-transplant cyclophosphamide combined with anti-thymocyte globulin as graft-versus-host disease prophylaxis for allogeneic hematopoietic cell transplantation in high-risk acute myeloid leukemia and myelodysplastic syndrome","volume":"144","author":"Alanzi","year":"2021","journal-title":"Acta Haematol"},{"issue":"74","key":"10.1016\/j.jtct.2021.09.020_bib0035","first-page":"1","article-title":"Treatment of infections due to MDR gram negative bacteria","volume":"6","author":"Bassetti","year":"2019","journal-title":"Front Med"},{"key":"10.1016\/j.jtct.2021.09.020_bib0036","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s40121-021-00408-8","article-title":"The impact of carbapenem resistance on mortality in patients with Klebsiella pneumoniae bloodstream infection: an individual patient data meta-analysis of 1952 patients","volume":"10","author":"Maraolo","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jtct.2021.09.020_bib0037","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijmmb.2021.04.002","article-title":"Management of serious infections caused by metallo \u03b2-lactamases with or without OXA-48-like expressing Enterobacterales with aztreonam and ceftazidime\/avibactam combination: Dosing strategy for better clinical outcome","volume":"39","author":"Veeraraghavan","year":"2021","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.jtct.2021.09.020_bib0038","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.bbmt.2019.04.023","article-title":"Impact of preemptive granulocyte infusions during febrile neutropenia in patients colonized with carbapenem-resistant gram-negative bacteria undergoing haploidentical transplantation","volume":"25","author":"Jaiswal","year":"2019","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721012628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721012628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:01:16Z","timestamp":1763002876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636721012628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2666636721012628"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.09.020","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haploidentical transplantation is feasible and associated with reasonable outcomes despite major infective complications\u2013A single center experience from India","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}